Cemtrex (CETX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CETX SEC filings page.
Cemtrex (CETX) reported $71.2M in revenue over the twelve months to Jun 30, 2026, down 6.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue expansion is reaching operations, but below-operating-line losses and reinvestment still determine the reported outcome.
In FY2025, operating income turned positive at$510K while net income was a-$28.1M loss; that unusually wide operating-to-net-income disconnect means the reported loss is being driven mainly below the operating line, not by the core cost structure. Operating cash flow was only$159K while free cash flow was-$1.8M , so the improvement in operating results had not yet translated into cash after reinvestment.
The margin pattern is consistent with better gross-profit retention as the business expanded: gross margin reached
The balance sheet remains liability-heavy: FY2025 total liabilities were
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cemtrex's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cemtrex held $5.0M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $159K of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Cemtrex scores 85/100 among other emerging companies.
Cemtrex had 7M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Cemtrex scores 7/100 among other emerging companies.
Cemtrex spent $2.4M on research and development in fiscal year 2025, which was 3.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Cemtrex scores 17/100 among other emerging companies.
Cemtrex reported revenue of $76.5M in fiscal year 2025, against $66.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Cemtrex scores 60/100 among other emerging companies.
Cemtrex's operations generated $159K of cash in fiscal year 2025, against $3.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Cemtrex scores 88/100 among other emerging companies.
Cemtrex's cash, cash equivalents and investments came to $5.0M at the end of fiscal year 2025, against $39.1M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Cemtrex scores 19/100 among other emerging companies.
Cemtrex scores -1.08, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.4M) relative to total liabilities ($39.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cemtrex passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Cemtrex reported a net loss of $28.1M while generating $159K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Cemtrex earns $0.24 in operating income for every $1 of interest expense ($510K vs $2.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Cemtrex generated $18.4M in revenue in Q3 2026. This represents an increase of 8.7% from the same quarter a year earlier. Against the prior quarter it is up 2.1%.
Cemtrex's EBITDA was -$611K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 85.6% from the same quarter a year earlier. Against the prior quarter it is up 63.1%.
Cemtrex reported -$4.5M in net income in Q3 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is down 593.9%.
Cash & Balance Sheet
Cemtrex recorded an outflow of $220K in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 112.7% from the same quarter a year earlier. Against the prior quarter it is up 95.2%.
Cemtrex held $8.0M in cash against $8.6M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Cemtrex's gross margin was 41.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.
Cemtrex's operating margin was -6.5% in Q3 2026, reflecting core business profitability. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.6 percentage points.
Cemtrex's net profit margin was -24.3% in Q3 2026, showing the share of revenue converted to profit. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 29.3 percentage points.
Cemtrex's ROE was -14.0% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 106.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.6 percentage points.
Capital Allocation
Cemtrex invested $425K in research and development in Q3 2026. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.
Cemtrex invested $630K in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 731.4% from the same quarter a year earlier. Against the prior quarter it is up 311.2%.
Not reported for Q3 2026.
CETX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.4M+8.7% | $18.1M-33.7% | $16.1M+17.4% | $18.5M+2.2% | $17.0M+15.5% | $27.3M+58.8% | $13.7M-18.6% | $18.1M+9.3% |
| Cost of Revenue | $10.7M+12.0% | $11.2M-25.7% | $10.5M+30.8% | $11.5M+8.7% | $9.6M+8.9% | $15.1M+47.6% | $8.0M-17.9% | $10.6M+8.1% |
| Gross Profit | $7.7M+4.4% | $6.8M-43.7% | $5.6M-1.4% | $7.1M-7.0% | $7.4M+25.4% | $12.2M+75.3% | $5.7M-19.5% | $7.6M+11.1% |
| R&D Expenses | $425K+10.0% | $547K-29.7% | $501K-43.7% | $299K-56.9% | $387K-55.3% | $778K-18.2% | $890K+4.9% | $693K-25.9% |
| SG&A Expenses | $7.9M+7.8% | $8.0M+23.2% | $7.6M+12.5% | $7.7M+19.7% | $7.3M-7.0% | $6.5M-3.8% | $6.8M+2.3% | $6.4M-17.3% |
| Operating Income | -$1.2M-85.7% | -$2.2M-147.0% | -$2.8M-23.0% | -$1.2M-270.1% | -$642K+79.8% | $4.6M+547.3% | -$2.3M-209.0% | -$320K-1608.0% |
| EBITDA | -$611K-85.6% | -$1.7M-133.6% | -$2.4M-23.1% | -$788K-7689.5% | -$329K+88.5% | $4.9M+777.5% | -$1.9M-425.4% | $10K-41.0% |
| Interest Expense | $470K+1.9% | $562K+24.1% | $12.1M+2405.3% | $712K+51.0% | $462K-11.5% | $453K-23.6% | $484K-17.1% | $472K-62.2% |
| Income Tax | -$119K-947.9% | $74K-33.2% | $266K+120.9% | $490K+1469.3% | $14K-79.1% | $111K+10.5% | $121K+70.4% | -$36K |
| Net Income | -$4.5M+3.3% | $907K-89.5% | -$20.6M+28.5% | -$3.4M-175.8% | -$4.6M+48.4% | $8.6M+686.3% | -$28.8M-2281.3% | $4.4M-31.9% |
| EPS (Basic) | -$3.27+37.2% | $0.12-99.8% | -$7.91+97.9% | -$199.20-110.1% | -$5.21-760.4% | $72.19+102.4% | -$383.87-15627.2% | $1963.45+112.5% |
| EPS (Diluted) | -$3.27 | $0.11 | -$7.91 | -$199.20 | -$5.21 | $19.51 | -$383.87 | $1963.45+112.5% |
| Diluted Shares (Avg) | 1M | 10M | 3M | N/A | 890,432 | 440,146 | 74,210 | N/A |
CETX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $70.0M+49.1% | $70.7M+53.0% | $60.3M+29.2% | $47.8M+8.3% | $47.0M+7.2% | $46.2M-2.1% | $46.7M+3.1% | $44.1M-9.0% |
| Current Assets | $37.5M+27.9% | $37.9M+32.6% | $42.7M+47.1% | $29.0M+8.7% | $29.3M+11.0% | $28.6M+0.7% | $29.0M+10.0% | $26.7M-8.9% |
| Cash & Equivalents | $8.0M+13.4% | $6.6M+44.7% | $20.5M+385.4% | $5.0M+27.6% | $7.0M+8.7% | $4.5M+55.6% | $4.2M+49.0% | $3.9M-26.9% |
| Short-Term Investments | $3.7M | $5.0M | $0 | $0 | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% |
| Inventory | $8.0M+37.9% | $6.7M+9.8% | $7.4M-33.1% | $6.6M-5.8% | $5.8M-22.6% | $6.1M-17.0% | $11.1M+40.0% | $7.0M-20.0% |
| Accounts Receivable | $12.5M-1.3% | $13.3M+4.8% | $9.7M+5.4% | $13.1M+17.7% | $12.7M+62.5% | $12.7M+10.2% | $9.2M-7.1% | $11.2M+21.2% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $7.7M+107.3% | $7.7M+107.3% | $3.7M0.0% | $3.7M0.0% | $3.7M-12.5% | $3.7M-15.4% | $3.7M-15.4% | $3.7M-15.4% |
| Total Liabilities | $38.0M-11.8% | $36.0M-8.8% | $31.2M-35.2% | $39.1M-0.2% | $43.1M-0.8% | $39.5M-6.1% | $48.2M+26.8% | $39.2M-2.4% |
| Current Liabilities | $24.3M-0.2% | $24.2M+2.8% | $18.0M-27.9% | $23.8M+28.1% | $24.4M+74.2% | $23.6M+30.2% | $24.9M-13.2% | $18.6M-32.0% |
| Non-Current Liabilities | $13.7M-27.0% | $11.8M-25.9% | $13.3M-42.9% | $15.2M-25.8% | $18.7M-36.5% | $15.9M-33.6% | $23.3M+150.5% | $20.6M+61.1% |
| Long-Term Debt | $8.6M+1.2% | $8.8M-7.8% | $8.0M-32.4% | $4.6M-65.4% | $8.5M-49.8% | $9.5M-56.0% | $11.9M | $13.3M+33.6% |
| Total Equity | $32.0M+730.7% | $34.7M+415.9% | $29.1M+1965.3% | $8.7M+85.1% | $3.9M+7932.4% | $6.7M+43.5% | -$1.6M-123.1% | $4.7M-38.7% |
| Retained Earnings | -$123.5M-28.3% | -$119.0M-29.8% | -$120.0M-19.8% | -$99.4M-39.3% | -$96.3M-27.0% | -$91.7M-37.3% | -$100.1M-53.2% | -$71.4M-11.3% |
CETX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $410K-77.3% | -$4.4M-257.7% | -$892K+25.8% | -$3.3M-73.6% | $1.8M+167.9% | $2.8M+624.4% | -$1.2M+61.7% | -$1.9M-372.8% |
| Depreciation & Amortization | $582K+85.9% | $516K+66.2% | $412K+22.3% | $395K+19.5% | $313K-3.9% | $310K+1.8% | $337K-8.4% | $330K+0.7% |
| Stock-Based Compensation | N/A | N/A | $0-100.0% | N/A | $3K-59.0% | $3K-59.0% | $4K-45.9% | N/A |
| Capital Expenditures | $630K+731.4% | $153K-64.8% | $184K-80.1% | $496K-42.9% | $76K+2.4% | $436K+573.8% | $924K+218.0% | $868K-56.6% |
| Free Cash Flow | -$220K-112.7% | -$4.6M-293.2% | -$1.1M+49.4% | -$3.7M-36.7% | $1.7M+188.2% | $2.4M+634.6% | -$2.1M+38.0% | -$2.7M-108.7% |
| Investing Cash Flow | $694K+1615.7% | -$13.7M-3108.8% | -$253K+74.9% | -$1.5M-73.7% | -$46K-193.3% | -$428K-557.8% | -$1.0M-158.5% | -$851K+82.6% |
| Financing Cash Flow | $280K+227.4% | $3.6M+363.2% | $17.3M+624.8% | $3.0M+456.9% | $86K-96.7% | -$1.4M-636.8% | $2.4M+139.2% | $531K-84.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CETX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 41.7%-1.7pp | 37.9%-6.7pp | 34.8%-6.7pp | 38.0%-3.7pp | 43.4%+3.4pp | 44.6%+4.2pp | 41.5%-0.5pp | 41.8%+0.7pp |
| Operating Margin | -6.5%-2.7pp | -12.0%-29.0pp | -17.4%-0.8pp | -6.4%-4.6pp | -3.8%+17.9pp | 16.9%+22.9pp | -16.6%-12.2pp | -1.8%-1.7pp |
| Net Margin | -24.3%+3.0pp | 5.0%-26.7pp | -127.4% | -18.1%-42.6pp | -27.3%+33.8pp | 31.7%+40.3pp | -209.3% | 24.4%-14.8pp |
| Return on Equity | -14.0%+106.3pp | 2.6%-125.8pp | -70.7% | -38.6%-132.7pp | -120.3%+18607.3pp | 128.4%+159.8pp | N/A | 94.1%+9.4pp |
| Return on Assets | -6.4%+3.5pp | 1.3%-17.4pp | -34.1%+27.5pp | -7.0%-17.1pp | -9.9%+10.6pp | 18.7%+21.8pp | -61.6%-58.9pp | 10.1%-3.4pp |
| Current Ratio | 1.54+0.3x | 1.57+0.4x | 2.38+1.2x | 1.22-0.2x | 1.20-0.7x | 1.21-0.4x | 1.17+0.2x | 1.44+0.4x |
| Debt-to-Equity | 0.27-1.9x | 0.25-1.2x | 0.28 | 0.53-2.3x | 2.20-350.1x | 1.41-3.2x | N/A | 2.82+1.5x |
| Asset Turnover | 0.26-0.1x | 0.26-0.3x | 0.270.0x | 0.390.0x | 0.360.0x | 0.59+0.2x | 0.29-0.1x | 0.41+0.1x |
| FCF Margin | -1.2%-11.4pp | -25.3%-34.0pp | -6.7%+8.8pp | -20.2%-5.1pp | 10.2%+6.1pp | 8.7%+6.8pp | -15.5%+4.8pp | -15.1%-7.2pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cemtrex CETX | FY2025 | $76.5M | -$28.1M | -36.8% | $4.4M | 46/100 |
| Taoping Inc TAOP | FY2025 | $30.8M | -$10.1M | -32.6% | $7.8M | 25/100 |
| AtlasClear ATCH | FY2025 | $10.9M | $5.8M | 53.0% | $28.5M | 37/100 |
| Ryvyl RVYL | FY2025 | $11.1M | -$17.5M | N/A | $10.0M | 28/100 |
| Brand Engagement BNAI | FY2025 | $275K | -$8.6M | N/A | $79.5M | — |
| OLB Group Inc OLB | FY2025 | $8.7M | -$5.9M | -67.7% | $6.5M | 18/100 |
Where Cemtrex Ranks
Frequently Asked Questions
What is Cemtrex's annual revenue?
Cemtrex (CETX) reported $76.5M in total revenue for fiscal year 2025. This represents a 14.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cemtrex's revenue growing?
Cemtrex (CETX) revenue grew by 14.4% year-over-year, from $66.9M to $76.5M in fiscal year 2025.
Is Cemtrex profitable?
No, Cemtrex (CETX) reported a net income of -$28.1M in fiscal year 2025, with a net profit margin of -36.8%.
What is Cemtrex's EBITDA?
Cemtrex (CETX) had EBITDA of $1.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Cemtrex have?
As of fiscal year 2025, Cemtrex (CETX) had $5.0M in cash and equivalents against $4.6M in long-term debt.
What is Cemtrex's gross margin?
Cemtrex (CETX) had a gross margin of 42.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Cemtrex's operating margin?
Cemtrex (CETX) had an operating margin of 0.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Cemtrex's net profit margin?
Cemtrex (CETX) had a net profit margin of -36.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Cemtrex's return on equity (ROE)?
Cemtrex (CETX) has a return on equity of -322.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cemtrex's free cash flow?
Cemtrex (CETX) recorded an outflow of $1.8M in free cash flow during fiscal year 2025. This represents a 66.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cemtrex's operating cash flow?
Cemtrex (CETX) generated $159K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cemtrex's total assets?
Cemtrex (CETX) had $47.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cemtrex's capital expenditures?
Cemtrex (CETX) invested $1.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Cemtrex spend on research and development?
Cemtrex (CETX) invested $2.4M in research and development during fiscal year 2025.
What is Cemtrex's current ratio?
Cemtrex (CETX) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.
What is Cemtrex's debt-to-equity ratio?
Cemtrex (CETX) had a debt-to-equity ratio of 0.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cemtrex's return on assets (ROA)?
Cemtrex (CETX) had a return on assets of -58.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cemtrex's P/E ratio?
Cemtrex (CETX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $4.4M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cemtrex's price-to-sales ratio?
Cemtrex (CETX) trades at 0.1x sales, its market capitalization divided by revenue of $71.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.4M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cemtrex's Altman Z-Score?
Cemtrex (CETX) has an Altman Z-Score of -1.08, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cemtrex's Piotroski F-Score?
Cemtrex (CETX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cemtrex's earnings high quality?
Cemtrex (CETX) reported a net loss of $28.1M while generating $159K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cemtrex cover its interest payments?
Cemtrex (CETX) has an interest coverage ratio of 0.24x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Cemtrex?
Cemtrex (CETX) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.